Pierre Demoyen is the founder of Invectys Therapeutics. Invectys Therapeutics has raised $44M in total funding. Latest round: Series A.
Pierre Langlade Demoyen is the founder and CEO of Invectys Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapeutic cancer vaccines. He founded the company in April 2010 in Paris, France, and continues to lead its progress through clinical trials and fundraising efforts.
Full founder directory · Investor directory · Company funding database · Fundraising library